Interaction between mouse adenovirus type 1 and cell surface heparan sulfate proteoglycans

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Lenaerts, Liesbeth ^a   van Dam, Wim ^a   Persoons, Leentje ^a   Naesens, Lieve ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10; PROTEOHEPARAN SULFATE; ADENOVIRUS RECEPTOR; CANCER VACCINE; VIRUS RECEPTOR;

ADENOVIRUS; ADENOVIRUS 5; ANIMAL CELL; ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MOUSE; MOUSE ADENOVIRUS TYPE 1; NONHUMAN; OVARY CARCINOMA; PROTEIN INTERACTION; SULFATION; TUMOR CELL LINE; VIRUS ATTACHMENT; VIRUS PARTICLE; ANIMAL; GENE VECTOR; METABOLISM; PROTEIN BINDING;

ADENOVIRIDAE; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS TYPE 5; MURINE ADENOVIRUS 1;

ADENOVIRIDAE; ANIMALS; CANCER VACCINES; CELL LINE, TUMOR; GENETIC VECTORS; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; MICE; PROTEIN BINDING; RECEPTORS, VIRUS;

EID: 84856718070     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031454     Document Type: Article

References (35)

1. Rein DT, Breidenbach M, Curiel DT, (2006) Current developments in adenovirus-based cancer gene therapy. Future Oncol 2: 137-143.
2. Alemany R, Curiel DT, (2001) CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors. Gene Ther 8: 1347-1353.
3. Smith T, Idamakanti N, Kylefjord H, Rollence M, King L, et al. (2002) In vivo hepatic adenoviral gene delivery occurs independently of the coxsackievirus-adenovirus receptor. Mol Ther 5: 770-779.
4. Parker AL, Waddington SN, Nicol CG, Shayakhmetov DM, Buckley SM, et al. (2006) Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes. Blood 108: 2554-2561.
5. Kalyuzhniy O, Di Paolo NC, Silvestry M, Hofherr SE, Barry MA, et al. (2008) Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo. Proc Natl Acad Sci U S A 105: 5483-5488.
6. Waddington SN, McVey JH, Bhella D, Parker AL, Barker K, et al. (2008) Adenovirus serotype 5 hexon mediates liver gene transfer. Cell 132: 397-409.
7. Sarrazin S, Lamanna WC, Esko JD, (2011) Heparan sulfate proteoglycans. Cold Spring Harb Perspect Biol 3: a004952.
8. Bishop JR, Schuksz M, Esko JD, (2007) Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446: 1030-1037.
9. Chen Y, Gotte M, Liu J, Park PW, (2008) Microbial subversion of heparan sulfate proteoglycans. Mol Cells 26: 415-426.
10. Jonsson MI, Lenman AE, Frangsmyr L, Nyberg C, Abdullahi M, et al. (2009) Coagulation factors IX and X enhance binding and infection of adenovirus types 5 and 31 in human epithelial cells. J Virol 83: 3816-3825.
11. Zaiss AK, Lawrence R, Elashoff D, Esko JD, Herschman HR, (2011) Differential effects of murine and human factor X on adenovirus transduction via cell surface heparan sulfate. J Biol Chem 286: 24535-24543.
12. Dechecchi MC, Tamanini A, Bonizzato A, Cabrini G, (2000) Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions. Virology 268: 382-390.
13. Dechecchi MC, Melotti P, Bonizzato A, Santacatterina M, Chilosi M, et al. (2001) Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5. J Virol 75: 8772-8780.
14. Bayo-Puxan N, Cascallo M, Gros A, Huch M, Fillat C, et al. (2006) Role of the putative heparan sulfate glycosaminoglycan-binding site of the adenovirus type 5 fiber shaft on liver detargeting and knob-mediated retargeting. J Gen Virol 87: 2487-2495.
15. Di Paolo NC, Kalyuzhniy O, Shayakhmetov DM, (2007) Fiber shaft-chimeric adenovirus vectors lacking the KKTK motif efficiently infect liver cells in vivo. J Virol 81: 12249-12259.
16. Xie J, Chiang L, Contreras J, Wu K, Garner JA, et al. (2006) Novel fiber-dependent entry mechanism for adenovirus serotype 5 in lacrimal acini. J Virol 80: 11833-11851.
17. Lenaerts L, Daelemans D, Geukens N, De Clercq E, Naesens L, (2006) Mouse adenovirus type 1 attachment is not mediated by the coxsackie-adenovirus receptor. FEBS Lett 580: 3937-3942.
18. Charles PC, Guida JD, Brosnan CF, Horwitz MS, (1998) Mouse adenovirus type-1 replication is restricted to vascular endothelium in the CNS of susceptible strains of mice. Virology 245: 216-228.
19. Lenaerts L, Verbeken E, De Clercq E, Naesens L, (2005) Mouse adenovirus type 1 infection in SCID mice: an experimental model for antiviral therapy of systemic adenovirus infections. Antimicrob Agents Chemother 49: 4689-4699.
20. Raman S, Hsu TH, Ashley SL, Spindler KR, (2009) Usage of integrin and heparan sulfate as receptors for mouse adenovirus type 1. J Virol 83: 2831-2838.
21. Lenaerts L, McVey JH, Baker AH, Denby L, Nicklin S, et al. (2009) Mouse adenovirus type 1 and human adenovirus type 5 differ in endothelial cell tropism and liver targeting. J Gene Med 11: 119-127.
22. Laremore TN, Zhang F, Dordick JS, Liu J, Linhardt RJ, (2009) Recent progress and applications in glycosaminoglycan and heparin research. Curr Opin Chem Biol 13: 633-640.
23. Gupta P, Oegema TR Jr, Brazil JJ, Dudek AZ, Slungaard A, et al. (1998) Structurally specific heparan sulfates support primitive human hematopoiesis by formation of a multimolecular stem cell niche. Blood 92: 4641-4651.
24. Bradshaw AC, Parker AL, Duffy MR, Coughlan L, van Rooijen N, et al. (2010) Requirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor X. PLoS Pathog 6: e1001142.
25. Crawford-Miksza L, Schnurr DP, (1996) Analysis of 15 adenovirus hexon proteins reveals the location and structure of seven hypervariable regions containing serotype-specific residues. J Virol 70: 1836-1844.
26. Alba R, Bradshaw AC, Parker AL, Bhella D, Waddington SN, et al. (2009) Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer. Blood 114: 965-971.
27. Duffy MR, Bradshaw AC, Parker AL, McVey JH, Baker AH, (2011) A cluster of basic amino acids in the factor X serine protease mediate surface attachment of adenovirus:FX complexes. J Virol 85: 10914-10919.
28. Monteiro RQ, Rezaie AR, Bae JS, Calvo E, Andersen JF, et al. (2008) Ixolaris binding to factor X reveals a precursor state of factor Xa heparin-binding exosite. Protein Sci 17: 146-153.
29. Nogami K, Freas J, Manithody C, Wakabayashi H, Rezaie AR, et al. (2004) Mechanisms of interactions of factor X and factor Xa with the acidic region in the factor VIII A1 domain. J Biol Chem 279: 33104-33113.
30. Rezaie AR, (2000) Heparin-binding exosite of factor Xa. Trends Cardiovasc Med 10: 333-338.
31. Yip GW, Smollich M, Gotte M, (2006) Therapeutic value of glycosaminoglycans in cancer. Mol Cancer Ther 5: 2139-2148.
32. Fuster MM, Esko JD, (2005) The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer 5: 526-542.
33. Kritz AB, Nicol CG, Dishart KL, Nelson R, Holbeck S, et al. (2007) Adenovirus 5 Fibers Mutated at the Putative HSPG-binding Site Show Restricted Retargeting with Targeting Peptides in the HI Loop. Mol Ther 15: 741-749.
34. Filmus J, Capurro M, Rast J, (2008) Glypicans. Genome Biol 9: 224.
35. Habuchi H, Miyake G, Nogami K, Kuroiwa A, Matsuda Y, et al. (2003) Biosynthesis of heparan sulphate with diverse structures and functions: two alternatively spliced forms of human heparan sulphate 6-O-sulphotransferase-2 having different expression patterns and properties. Biochem J 371: 131-142.